original ) (raw )Dopamine/Serotonin Receptor Ligands. 12 1 : SAR Studies on Hexahydro-dibenz[ d , g ]azecines Lead to 4-Chloro-7-methyl-5,6,7,8,9,14-hexahydrodibenz[ d,g ]azecin-3-ol, the First Picomolar D 5 -Selective Dopamine-Receptor Antagonist
Christoph Enzensperger
Journal of Medicinal Chemistry, 2006
View PDFchevron_right
Evaluation of 1‐Arylpiperazine Derivative of Hydroxybenzamides as 5‐HT1A and 5‐HT7 Serotonin Receptor Ligands: An Experimental and Molecular Modeling …
Jola Jas
…, 2011
View PDFchevron_right
Evaluation of 1-arylpiperazine derivative of hydroxybenzamides as 5-HT1A and 5-HT7 serotonin receptor ligands: An experimental and molecular modeling approach
Adam Bucki
Journal of Heterocyclic Chemistry, 2011
View PDFchevron_right
Synthesis and structure-affinity relationships of novel N-(1-ethyl-4-methylhexahydro-1,4-diazepin-6-yl)pyridine-3-carboxamides with potent serotonin 5-HT3 and dopamine D2 receptor antagonistic activity
Martha Ramirez
2003
View PDFchevron_right
Dopamine/serotonin receptor ligands. Part 17: A cross-target SAR approach: Affinities of azecine-styled ligands for 5-HT2A versus D1 and D2 receptors
Christoph Enzensperger
Bioorganic & Medicinal Chemistry Letters, 2008
View PDFchevron_right
Dopamine/Serotonin Receptor Ligands. Part IV [1]: Synthesis and Pharmacology of Novel 3-Benzazecines and 3-Benzazonines as Potential 5-HT2A and Dopamine Receptor Ligands
Hussein El-subbagh
Archiv der Pharmazie, 2002
View PDFchevron_right
Dopamine/Serotonin Receptor Ligands. 10: 1 SAR Studies on Azecine-type Dopamine Receptor Ligands by Functional Screening at Human Cloned D 1 , D 2L , and D 5 Receptors with a Microplate Reader Based Calcium Assay Lead to a Novel Potent D 1 /D 5 Selective Antagonist
Sherif Rostom , Matthias Kassack , Hussein El-subbagh
Journal of Medicinal Chemistry, 2006
View PDFchevron_right
N-(1-Benzylpyrrolidin-3-yl)arylbenzamides as potent and selective human dopamine D4 antagonists
Jalaj Arora
Bioorganic & Medicinal Chemistry Letters, 2004
View PDFchevron_right
The arylpiperazine derivatives N-(4-cyanophenylmethyl)- 4-(2-diphenyl)-1-piperazinehexanamide and N-benzyl-4- (2-diphenyl)-1-piperazinehexanamide exert a long-lasting inhibition of human serotonin 5-HT 7 receptor binding and cAMP signaling
Marián Castro
View PDFchevron_right
C5-Substituted Derivatives of 5-OMe-BPAT: Synthesis and Interactions with Dopamine D2 and Serotonin 5-HT1A Receptors
Martin Tulp
Bioorganic & Medicinal Chemistry, 1999
View PDFchevron_right
New Esters of 4-Amino-5-chloro-2-methoxybenzoic Acid as Potent Agonists and Antagonists for 5-HT4 Receptors
tiziano croci
Journal of Medicinal Chemistry, 1997
View PDFchevron_right
Dibenzazecine compounds with a novel dopamine/5HT2A receptor profile and 3D-QSAR analysis
Michael Wiese
BMC pharmacology, 2006
View PDFchevron_right
Dopamine/Serotonin Receptor Ligands, Part III [1]: Synthesis and Biological Activities of 7, 7′—Alkylene-bis-6, 7, 8, 9, 14, 15-hexahydro-5H-benz[d]indolo[2, 3-g]azecines — Application of the Bivalent Ligand Approach to a Novel Type of Dopamine Receptor Antagonist
Ashraf Abadi
Archiv Der Pharmazie, 2002
View PDFchevron_right
Resolved 6,7,8,9-tetrahydro-N,N-dimethyl-3H-benz[e]indol-8-amine: central dopamine and serotonin receptor stimulating properties
Kjell Svensson
Journal of Medicinal Chemistry, 1989
View PDFchevron_right
New Esters of 4-Amino-5-chloro-2-methoxybenzoic Acid as Potent Agonists and Antagonists for 5-HT4 Receptors
Béatrice Brémont
Journal of Medicinal Chemistry, 1997
View PDFchevron_right
Synthesis and Pharmacological Evaluation of 1-[(1,2-Diphenyl-1 H -4-imidazolyl)methyl]-4-phenylpiperazines with Clozapine-Like Mixed Activities at Dopamine D 2 , Serotonin, and GABA A Receptors
Laura Dazzi
Journal of Medicinal Chemistry, 2002
View PDFchevron_right
Dopamine/serotonin receptor ligands. Part 15: Oxygenation of the benz-indolo-azecine LE 300 leads to novel subnanomolar dopamine D1/D5 antagonists
Christoph Enzensperger
Bioorganic & Medicinal Chemistry Letters, 2007
View PDFchevron_right
The synthesis of cyclic and acyclic long-chain arylpiperazine derivatives of salicylamide as serotonin receptor ligands
Piotr kowalski
Journal of Heterocyclic Chemistry, 2008
View PDFchevron_right
trans-2,6-, 3,6- and 4,6-Diaza-5,6,6a,7,8,12b-hexahydrobenzo[C]phenanthrene-10,11-diols as dopamine agonists
Yu-Gui Gu
Bioorganic & Medicinal Chemistry Letters, 1999
View PDFchevron_right
Derivatives of cis-2-Amino-8-hydroxy-1-methyltetralin: Mixed 5-HT1A-Receptor Agonists and Dopamine D2-Receptor Antagonists
Tommy Lewander
Journal of Medicinal Chemistry, 1995
View PDFchevron_right
Synthesis and receptor affinities of some conformationally restricted analogues of the dopamine D1 selective ligand (5R)-8-chloro-2,3,4,5-tetrahydro-3-methyl-5-phenyl- 1H-3-benzazepin-7-ol
R. Chipkin , Donald Hou
Journal of medicinal chemistry, 1989
View PDFchevron_right
Selective, centrally acting serotonin 5-HT2 antagonists. 1. 2- and 6-Substituted 1-phenyl-3-(4-piperidinyl)-1H-indoles
Jorn Arnt
Journal of Medicinal Chemistry, 1992
View PDFchevron_right
D2 Dopaminergic and 5-HT1A Serotonergic Activity of 2-(1-Naphthyl)ethyl- and 2-(2-Naphthyl)ethyl Amines
Goran Roglic
Archiv der Pharmazie, 2003
View PDFchevron_right
Structure−Activity Relationships for a Novel Series of Dopamine D2-like Receptor Ligands Based on N-Substituted 3-Aryl-8-azabicyclo[3.2.1]octan-3-ol
Jonathan Katz
Journal of Medicinal Chemistry, 2008
View PDFchevron_right
Interaction of AZA analogs of chlorpromazine with the dopamine D2 receptor
Tahira Farooqui
General Pharmacology: The Vascular System, 1993
View PDFchevron_right
4-(4-Fluorobenzoyl)-1-[2-(4-iodo-2,5-dimethoxyphenyl)ethyl]piperidine and its derivatives: synthesis and affinity at 5-HT2A, 5-HT2B and 5-HT2C serotonin receptors
Gianfabio Giorgioni
European Journal of Medicinal Chemistry, 1999
View PDFchevron_right
Dopamine receptor agonists: 3-allyl-6-chloro-2,3,4,5-tetrahydro-1-(4-hydroxyphenyl)-1H-3-benzazepine-7,8-diol and a series of related 3-benzazepines
Robert Demarinis
Journal of Medicinal Chemistry, 1986
View PDFchevron_right
Dibenzofuranylethylamines as 5-HT2A/2C Receptor Agonists
Thirumal Yempala
ACS omega, 2020
View PDFchevron_right
Introduction of a methyl group in α- or β-position of 1-heteroarylethyl-4-phenyl-piperazines affects their dopaminergic/serotonergic properties
Vukic Soskic
Archiv der Pharmazie, 2001
View PDFchevron_right
N,N-Dimethyl-[9-(arylsulfonyl)-2,3,4,9-tetrahydro-1H-carbazol-3-yl]amines as novel, potent and selective 5-HT6 receptor antagonists
Ramakrishna Nirogi
Bioorganic & Medicinal Chemistry Letters, 2012
View PDFchevron_right
Hexahydrobenzo[a]phenanthridines: novel dopamine D3 receptor ligands
Richard Mailman
European Journal of Pharmacology, 1993
View PDFchevron_right
Interactions of N-{[2-(4-phenyl-piperazin-1-yl)-ethyl]-phenyl}-2-aryl-2-yl-acetamides and 1-{[2-(4-phenyl-piperazin-1-yl)-ethyl]-phenyl}-3-aryl-2-yl-ureas with dopamine D2 and 5-hydroxytryptamine 5HT1A receptors
Đurđica Ignjatović
Bioorganic & Medicinal Chemistry Letters, 2012
View PDFchevron_right
Characterization of a novel 5-HT4 receptor antagonist of the azabicycloalkyl benzimidazolone class: DAU 6285
Joel Bockaert
Naunyn-Schmiedeberg's Archives of Pharmacology, 1992
View PDFchevron_right
Synthesis, dopamine D 2 receptor binding studies and docking analysis of 5-[3-(4-arylpiperazin-1-yl)propyl]-1 H-benzimidazole, 5-[2-(4-arylpiperazin-1-yl)ethoxy]-1 H-benzimidazole and their analogs
Goran Roglic
European Journal of Medicinal Chemistry, 2005
View PDFchevron_right